Merck Sharp & Dohme Corp. v. Wyeth LLC
Leave to file the Reply Reports and the Rebuttal Opinion was granted because the proposed reports were responsive to issues first raised by the defendant's expert reports, could not reasonably have been anticipated and therefore did not constitute impermissible splitting, were necessary to assist the Court on complex scientific matters (including interpretation of patent prosecution communications under s.53.1), and their admission would not cause substantial prejudice to the defendant; accordingly the motion was granted and costs awarded to Merck.
- Citation
- 2020 FC 1087
- Parties
- Plaintiff: Merck Sharp & Dohme Corp.; Plaintiff: Merck Canada Inc.; Defendant: Wyeth LLC
- Court
- Federal Court
- Jurisdiction
- Canada
- Judgment Date
- 24 November 2020
- Procedural Posture
- Patent Invalidity (impeachment) Action / Pre Trial Motion for Leave to File Reply Expert Reports
- Outcome
- Motion granted
- Legal Topics
- Reply Expert Evidence, Admissibility of Expert Evidence, Patent Prosecution Communications (s.53.1 Patents Act), Obviousness, Anticipation, Double Patenting, Costs
- Source Language
- English
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Merck Sharp & Dohme Corp.
Plaintiff
Merck Canada Inc.
Plaintiff
Wyeth LLC
Defendant
Procedural Posture
Patent Invalidity (impeachment) Action / Pre Trial Motion for Leave to File Reply Expert Reports
Legal Issues
- 1 Whether Merck should be granted leave to serve and file reply expert reports and a rebuttal opinion
- 2 Whether the proposed reply evidence is responsive rather than splitting the plaintiff's case
- 3 Whether the rebuttal opinion on patent office communications is permissible under s.53.1 of the Patent Act
Ratio Decidendi
Leave to file the Reply Reports and the Rebuttal Opinion was granted because the proposed reports were responsive to issues first raised by the defendant's expert reports, could not reasonably have been anticipated and therefore did not constitute impermissible splitting, were necessary to assist the Court on complex scientific matters (including interpretation of patent prosecution communications under s.53.1), and their admission would not cause substantial prejudice to the defendant; accordingly the motion was granted and costs awarded to Merck.
Court Disposition
Motion granted
Orders
- The Plaintiffs' Reply Motion is granted
- The Plaintiffs are granted leave to file the Reply Reports of Drs. Paton, Kasper and Petrovsky and the Rebuttal Opinion of Dr. Paton
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment